Summit Therapeutics Inc. Assets
Summit Therapeutics Inc. (SMMT) had Assets of GBP 71.79 million as of 2020-03-31, per its 6-K filed 2020-06-02.
Discontinued › Notes
ifrs-full:Assets · last filed 2020-06-02
- 2020-03-31: Assets 71.79M GBP.
- 2019-12-31: Assets 73.12M GBP.
- 2019-10-31: Assets 39.35M GBP.
- 2019-07-31: Assets 48.42M GBP.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2020-03-31 | 71.79M GBP 6-K · filed 2020-06-02 | |
| 2019-12-31 | 73.12M GBP 6-K · filed 2020-06-02 | |
| 2019-10-31 | 39.35M GBP 6-K · filed 2019-12-17 | |
| 2019-07-31 | 48.42M GBP 6-K · filed 2019-10-11 | |
| 2019-04-30 | 53.65M GBP 6-K · filed 2019-06-12 | |
| 2019-01-31 | 60.63M GBP 20-F · filed 2020-04-30 | 59.77M GBP 20-F · filed 2019-03-29 |
| 2018-10-31 | 44.83M GBP 6-K · filed 2018-12-11 | |
| 2018-07-31 | 46.77M GBP 6-K · filed 2018-09-20 | |
| 2018-04-30 | 63.74M GBP 6-K · filed 2018-06-05 | |
| 2018-01-31 | 55.17M GBP 20-F · filed 2020-04-30 | 53.96M GBP 20-F · filed 2018-04-13 |
| 2017-01-31 | 37.59M GBP 20-F · filed 2018-04-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |